Dream Plus Report issue

For profit
Founded: Cheongju-Si Korea, Republic of (1980)
Status: No NME R&D (1980)

Organization Overview

First Clinical Trial
2012
NCT01852487
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

pumpkin seeds (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1